A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice

Chemoradiotherapy is a safe and effective treatment option for a wide range of muscle-invasive bladder carcinoma patients with 2-yr locoregional disease-free-survival of 76%. Results in daily practice are comparable with trial outcomes. Lymph node irradiation and carcinoma in situ were not related t...

Full description

Bibliographic Details

Published in:	European urology open science (Online) Vol. 39; pp. 7 - 13
Main Authors:	de Ruiter, Ben-Max, van de Kamp, Maaike W., van Steenbergen, Jonah P.Z., Franckena, Martine, Boormans, Joost L., de Feijter, Jeantine M., Bins, Adriaan D., Hulshof, Maarten C.C.M., de Reijke, Theo M., Schaake, Eva, Oddens, Jorg R.
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01-05-2022 Elsevier
Subjects:	Bladder Cancer Carcinoma Chemoradiotherapy Therapeutics Transitional cell Carcinoma Transitional cell Chemoradiotherapy Therapeutics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!